Shares of GSK plc (LON:GSK - Get Free Report) crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 1,494.06 ($18.70) and traded as low as GBX 1,330.50 ($16.65). GSK shares last traded at GBX 1,336.04 ($16.72), with a volume of 4,729,620 shares trading hands.
Wall Street Analyst Weigh In
A number of equities analysts recently commented on GSK shares. Berenberg Bank decreased their target price on GSK from GBX 1,820 ($22.78) to GBX 1,600 ($20.02) and set a "buy" rating on the stock in a report on Friday, November 29th. JPMorgan Chase & Co. reaffirmed an "underweight" rating on shares of GSK in a research note on Wednesday, December 11th. Finally, Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and set a GBX 1,850 ($23.15) price objective on shares of GSK in a research note on Tuesday, September 3rd. One analyst has rated the stock with a sell rating, one has given a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat.com, GSK currently has an average rating of "Moderate Buy" and an average target price of GBX 1,805.83 ($22.60).
Check Out Our Latest Stock Analysis on GSK
GSK Price Performance
The firm's fifty day moving average price is GBX 1,367.26 and its 200 day moving average price is GBX 1,493.02. The stock has a market cap of £54.94 billion, a PE ratio of 1,191.59, a P/E/G ratio of 1.24 and a beta of 0.31. The company has a quick ratio of 0.73, a current ratio of 0.82 and a debt-to-equity ratio of 123.04.
GSK Dividend Announcement
The firm also recently announced a dividend, which will be paid on Thursday, January 9th. Stockholders of record on Thursday, November 14th will be given a dividend of GBX 15 ($0.19) per share. This represents a dividend yield of 1.03%. The ex-dividend date of this dividend is Thursday, November 14th. GSK's dividend payout ratio is 5,309.73%.
Insider Buying and Selling at GSK
In related news, insider Jonathan Symonds bought 1,500 shares of the stock in a transaction dated Friday, December 20th. The stock was purchased at an average cost of GBX 1,315 ($16.46) per share, with a total value of £19,725 ($24,684.02). Insiders have purchased a total of 8,658 shares of company stock worth $11,950,792 over the last ninety days. Company insiders own 1.61% of the company's stock.
About GSK
(
Get Free Report)
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.
Featured Articles
Before you consider GSK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GSK wasn't on the list.
While GSK currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
